EX-2.1
from S-1
132 pages
Agreement and Plan of Merger by and Among: Aeglea Biotherapeutics, Inc., a Delaware Corporation; Aspen Merger Sub I, Inc., a Delaware Corporation; Sequoia Merger Sub II, LLC, a Delaware Limited Liability Company; and Spyre Therapeutics, Inc., a Delaware Corporation Dated as of June 22, 2023
12/34/56
EX-2.1
from S-1/A
132 pages
Agreement and Plan of Merger by and Among: Aeglea Biotherapeutics, Inc., a Delaware Corporation; Aspen Merger Sub I, Inc., a Delaware Corporation; Sequoia Merger Sub II, LLC, a Delaware Limited Liability Company; and Spyre Therapeutics, Inc., a Delaware Corporation Dated as of June 22, 2023
12/34/56
EX-2.1
from 8-K
132 pages
Agreement and Plan of Merger by and Among: Aeglea Biotherapeutics, Inc., a Delaware Corporation; Aspen Merger Sub I, Inc., a Delaware Corporation; Sequoia Merger Sub II, LLC, a Delaware Limited Liability Company; and Spyre Therapeutics, Inc., a Delaware Corporation Dated as of June 22, 2023
12/34/56